BioAge Labs Ratios (2023-2026) | BIOA

Ratios Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter) -219.02%-478.57%-496.30%-504.84%-374.06%
EBT Margin (Quarter) -898.14%-1,059.58%-1,390.12%-504.58%-801.12%
EBIT Margin (Quarter) -1,133.43%-1,026.99%-1,126.58%-923.42%-915.40%
EBITDA Margin (Quarter) -1,133.43%-1,026.99%-1,126.58%-923.42%-915.40%
Operating Margin (Quarter) -1,133.43%-1,026.99%-1,126.58%-923.42%-915.40%
Net Margin (Quarter) -898.14%-1,059.58%-1,390.12%-504.58%-801.12%
FCF Margin (Quarter) -1,225.98%-834.49%-782.18%-921.47%-868.40%
Efficiency
Assets Average (Quarter) 347.81M351.04M332.99M313.62M299.99M346.27M
Invested Capital (Quarter) 6.00M6.00M6.00M6.00M5.00M3.50M2.00M0.50M
Asset Utilization Ratio (Quarter) 0.000.010.020.030.03
Leverage & Solvency
Interest Coverage Ratio (Quarter) -4.11-1.91-10.53-34.47-0.42-79.50-54.82-31.52-4.22-308.95-253.75
Debt Ratio (Quarter) 0.550.030.020.020.020.010.010.00
Times Interest Earned (Quarter) -4.11-1.91-10.53-34.47-0.42-79.50-54.82-31.52-4.22-308.95-253.75
Valuation
Enterprise Value (Quarter) -24.96M-173.99M-334.47M-354.06M-398.13M-297.01M-285.50M-281.10M-383.19M
Return Ratios
Return on Sales (Quarter) -0.09%-0.11%-0.14%-0.05%-0.08%
Return on Capital Employed (Quarter) -24.43%-25.00%-29.45%-31.03%-33.15%-30.78%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%